Table 3. Diagnostic value of MSCT combined with CA19-9, Bcl-2, and CYFRA21-1 in esophageal cancer.
Predictor | AUC | Standard error | Progressive Sig | Progressive 95% CI | |
---|---|---|---|---|---|
Lower limit | Upper limit | ||||
CA19-9 | 0.851 | 0.033 | <0.001 | 0.786 | 0.915 |
Bcl-2 | 0.738 | 0.045 | <0.001 | 0.649 | 0.826 |
CYFRA21-1 | 0.747 | 0.043 | <0.001 | 0.663 | 0.830 |
MSCT | 0.878 | 0.034 | <0.001 | 0.812 | 0.944 |
Combined | 0.959 | 0.016 | <0.001 | 0.927 | 0.990 |
MSCT, multi-slice spiral computed tomography; AUC, areas under the curve; CA19-9, carbohydrate antigen 19-9; Bcl-2, B-cell leukemia/lymphoma-2 protein; CYFRA21-1, cytokeratin 19 fragment antigen 21-1.